200689
乙基纤维素
viscosity 10 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
别名:
ethylcellulose
产品名称
乙基纤维素, viscosity 10 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
SMILES string
O1[C@H](C(C(C(C1COCC)OCC)OCC)OCC)O[C@@H]2C(OC(C(C2OCC)OCC)OCC)COCC
InChI key
MINRZDZESGXKDM-OLIDUAMRSA-N
form
powder
autoignition temp.
698 °F
extent of labeling
48% ethoxyl
refractive index
n20/D 1.47 (lit.)
viscosity
10 cP, 5 % in toluene/ethanol 80:20(lit.)
transition temp
softening point 155 °C
density
1.14 g/mL at 25 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
乙基纤维素（EC）是一种疏水性和生理惰性的纤维素衍生物。它被广泛用于制备生理剂型。它也可以用作聚合物涂层、颗粒乳液稳定剂和药学上有用的水性乳胶分散体。
Application
乙基纤维素可以用作制备用于控制药物释放的玉米醇溶蛋白基纳米纤维的起始材料。EC 的加入提高了复合纳米纤维的溶解性和机械性能。
它可以用于制备用于喷墨打印的石墨烯基油墨。这种印刷在 ITO 表面上的氧化石墨烯墨水可以用作无标记 DNA 传感的电极。
由于其独特的特性，如胃耐受性、生物相容性和对无毒易排泄产物的降解性，EC 被广泛用于口服和局部药物剂型，用于药物的控制释放。
它可以用于制备用于喷墨打印的石墨烯基油墨。这种印刷在 ITO 表面上的氧化石墨烯墨水可以用作无标记 DNA 传感的电极。
由于其独特的特性，如胃耐受性、生物相容性和对无毒易排泄产物的降解性，EC 被广泛用于口服和局部药物剂型，用于药物的控制释放。
Features and Benefits
- 无毒
- 稳定
- 可压缩
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Arif Z Nelson et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(11), 5671-5679 (2020-03-05)
Microfluidic tools and techniques for manipulating fluid droplets have become core to many scientific and technological fields. Despite the plethora of existing approaches to fluidic manipulation, non-Newtonian fluid phenomena are rarely taken advantage of. Here we introduce embedded droplet printing-a
Tetsuya Ozeki et al.
Biological & pharmaceutical bulletin, 35(11), 1926-1931 (2012-11-06)
Production of drug nanoparticles is an effective strategy to enhance solubility and oral absorption of water-insoluble drugs. The handling of drug nanoparticles has been an important issue in drug formulation because nanoparticles easily aggregate each other and redispersion of these
Kifayat Ullah Shah et al.
TheScientificWorldJournal, 2012, 842348-842348 (2012-06-01)
The design and fabrication of sustained/controlled release dosage forms, employing new excipients capable of extending/controlling the release of drugs from the dosage forms over prolonged periods, has worked well in achieving optimally enhanced therapeutic levels of the drugs. In this
Oguzhan Gunduz et al.
Pharmaceutical research, 30(1), 225-237 (2012-09-08)
To investigate a new microfluidic method for the continuous preparation of hollow-shell nanoparticles of a hydrophobic polymer and the simultaneous encapsulation within these of a hydrophilic active pharmaceutical ingredient. A specially designed and constructed microfluidic device which facilitates at a
Ghulam Murtaza
Acta poloniae pharmaceutica, 69(1), 11-22 (2012-05-12)
Ethylcellulose (EC) based microencapsulated drug delivery systems are being extensively studied throughout the world for achieving extended drug release and protecting the core substance from degradation. The in vitro evaluation of EC microcapsules have elucidated that their particle characteristics are
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持